JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB191052

Anti-Kv1.4/RK3 antibody

Be the first to review this product! Submit a review

|

(3 Publications)

Rabbit Polyclonal Kv1.4/RK3 antibody. Suitable for WB and reacts with Rat, Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human KCNA4 aa 300-350.

View Alternative Names

KCNA4L, KCNA4, Potassium voltage-gated channel subfamily A member 4, HPCN2, Voltage-gated K(+) channel HuKII, Voltage-gated potassium channel HBK4, Voltage-gated potassium channel HK1, Voltage-gated potassium channel subunit Kv1.4

1 Images
Western blot - Anti-Kv1.4/RK3 antibody (AB191052)
  • WB

Supplier Data

Western blot - Anti-Kv1.4/RK3 antibody (AB191052)

All lanes:

Western blot - Anti-Kv1.4/RK3 antibody (ab191052) at 0.5 µg/mL

Lane 1:

Rat brain tissue Lysate

Lane 2:

HY1080 Whole Cell Lysate

Lane 3:

PANC Whole Cell Lysate

Lane 4:

U87 Whole Cell Lysate

Lane 5:

SHG Whole Cell Lysate

Predicted band size: 73 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Rat, Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human KCNA4 aa 300-350. The exact immunogen used to generate this antibody is proprietary information.

P22459

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.5 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.5 µg/mL", "WB-species-notes": "<p></p>" }, "Cow": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
Preservative: 0.025% Sodium azide, 0.025% Thimerosal (merthiolate) Constituents: 2.5% BSA, 0.45% Sodium chloride, 0.1% Disodium hydrogenorthophosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Kv1.4 also known as RK3 functions as a voltage-gated potassium channel. It allows for potassium ions to move across the cell membrane in response to changes in membrane potential. This channel has a molecular mass around 75 kDa. Kv1.4 is mainly expressed in cardiac and neuronal tissues where it plays an important role in action potential repolarization. Its expression ensures proper electrical signaling in these tissues.
Biological function summary

The Kv1.4 channel contributes to the regulation of action potentials in both the heart and nervous system. It is part of a larger complex of potassium channels that work together to fine-tune neuronal excitability and muscle contraction. The function of Kv1.4 is essential for maintaining the balance of excitation and inhibition in cells impacting how electrical signals are transmitted.

Pathways

Kv1.4 has a significant role in the cardiac action potential pathway and the neural signaling pathway. In the cardiac pathway it interacts with other potassium channels like Kv1.2 and Kv1.1 to ensure the timely repolarization of the cardiac action potential. In neural tissues Kv1.4 affects neurotransmitter release and neuronal firing rates interacting with proteins such as synaptotagmin in the synaptic vesicle fusion process.

Kv1.4 mutations and dysregulation are connected to cardiac arrhythmias and epilepsy. Altered Kv1.4 function can disrupt the cardiac rhythm leading to arrhythmogenic conditions. In epilepsy abnormal Kv1.4 activity may lead to imbalanced neuronal excitability which can contribute to seizure disorders. Kv1.4 interacts with other proteins like Nav1.1 in these disease states to exacerbate or mitigate symptoms.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane (PubMed : 19912772, PubMed : 8495559). Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, and possibly other family members as well; channel properties depend on the type of alpha subunits that are part of the channel (PubMed : 8495559). Channel properties are modulated by cytoplasmic beta subunits that regulate the subcellular location of the alpha subunits and promote rapid inactivation. In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Homotetrameric KCNA4 forms a potassium channel that opens in response to membrane depolarization, followed by rapid spontaneous channel closure (PubMed : 19912772, PubMed : 8495559). Likewise, a heterotetrameric channel formed by KCNA1 and KCNA4 shows rapid inactivation (PubMed : 17156368).
See full target information KCNA4

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

BMC cancer 24:650 PubMed38802739

2024

CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi-Yu Zhang,Jian-Hao Xu,Jiang-Lei Zhang,Yu-Xin Lin,Jun Ou-Yang

Journal of neuroscience research 100:506-521 PubMed34935172

2021

Adult-onset hypothyroidism causes mechanical hypersensitivity due to peripheral nerve hyperexcitability based on voltage-gated potassium channel downregulation in male mice.

Applications

Unspecified application

Species

Unspecified reactive species

Machiko Suda,Yusuke Takatsuru,Izuki Amano,Shogo Haraguchi,Noriyuki Koibuchi

British journal of pharmacology 176:2780-2794 PubMed31074016

2019

Contribution of potassium channels to action potential repolarization of human embryonic stem cell-derived cardiomyocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Yin Wang,Renjun Zhu,Leslie Tung
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com